equity

Upcoming graduate student summit will showcase pathways to success within the biopharmaceutical industry

I am excited to join with Dr. Michael L. Lomax, President & CEO, UNCF; Dr. James Gillespie, President & Co-Founder, Center for Healthcare Innovation (CHI); and Dr. Chad Womack, Co-Founder and Executive Director of the Ernest E. Just Life Science Society on a collaboration to create new pathways to careers in the biopharmaceutical industry.

PhRMA awards $150,000 to community-based projects aimed at tackling inequities in access to COVID-19 testing, vaccines and therapeutics

The COVID-19 pandemic has widened health disparities, including the gap in average life expectancy and outcomes for many chronic diseases. These inequities in health status and outcomes among racial and ethnic groups often are rooted in community-level factors like where and how we live, work, and play; inherent bias; lack of adequate coverage and access …

PhRMA awards $150,000 to community-based projects aimed at tackling inequities in access to COVID-19 testing, vaccines and therapeutics Read More »

Addressing data challenges to improve health equity

The COVID-19 pandemic has shed light on the ways that systemic racism pervades nearly every facet of life – especially within our health care system. The biopharmaceutical industry is dedicated to tackling these issues head-on and addressing health disparities that disproportionately affect communities of color and other underserved communities. Driven by this commitment, PhRMA is …

Addressing data challenges to improve health equity Read More »

Promoting global vaccine equity while protecting innovation

America’s biopharmaceutical companies have successfully researched, developed and distributed billions of doses of multiple vaccines and therapeutics to halt the spread of COVID-19. The availability of COVID-19 vaccines has shifted the trajectory of the pandemic and is undoubtedly saving lives. Further, the approval of the first ever mRNA vaccines has the potential to usher in …

Promoting global vaccine equity while protecting innovation Read More »

A conversation with Ron Busby, Sr., President and CEO of the U.S. Black Chambers, Inc. on improving vaccine confidence in communities of color

The COVID-19 pandemic exposed and often exacerbated the significant systemic health inequities that underserved communities have faced for many years. Black Americans have been particularly affected by these inequalities. These inequities and resulting disparities foster mistrust and contribute to vaccine hesitancy.

PhRMA member companies share how they are improving clinical trial diversity

As part of the biopharmaceutical industry’s efforts to improve health outcomes for patients in underserved communities, PhRMA member companies are identifying ways to improve clinical trial diversity and reduce barriers to participation for Black and Brown communities. As these efforts continue to take shape, our industry is developing potential best practices and key learnings that …

PhRMA member companies share how they are improving clinical trial diversity Read More »

Diversifying clinical trials and fighting disease requires equity and trust

The COVID-19 pandemic has left no person unaffected, but Black Americans have been disproportionately impacted. Black adults are nearly four times more likely to be hospitalized from the virus and nearly three times more likely to die from the virus than their white counterparts. At the same time, recent polls highlight COVID-19 vaccine hesitancy within …

Diversifying clinical trials and fighting disease requires equity and trust Read More »

Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive

Last week, PhRMA submitted comments to the United States Patent and Trademark Office (USPTO) in response to a request for comments on the National Strategy for Expanding American Innovation. PhRMA’s comments focus on the types of initiatives and efforts that could be included in a national strategy to make the innovation ecosystem more diverse and …

Key takeaways: PhRMA comments to USPTO on how to make the innovation ecosystem more diverse and inclusive Read More »

Patients report unmet care needs despite rising telehealth use

Roughly a third of adults had a telehealth visit in the first 6 months of the pandemic, according to a new survey conducted by the Urban Institute. But not everyone who wanted a telehealth visit was able to access it, leaving some adults with unmet care needs.

New report highlights biopharmaceutical industry’s commitment to D&I

Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the workplace, in the communities in which they operate and in the patient communities in which they serve. The report examines the state of accelerating demographic changes and …

New report highlights biopharmaceutical industry’s commitment to D&I Read More »

Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US

This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. Outside of the novel coronavirus, major social issues have been brought to the forefront of public discourse. We understand that systematic racism is as real as any …

Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US Read More »

Sharing rebates can improve access to medicines and increase health equity

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Dr. Leah …

Sharing rebates can improve access to medicines and increase health equity Read More »

Systemic racism is as real as any disease, and our industry is not immune

This month, PhRMA published our commitment to racial equity and inclusion in the New York Times as well as in the Informer and the AfroAmerican, DC-based, Black-owned newspapers. This public declaration is an important milestone for our industry as we continue to take concrete steps to address systemic racism and work towards a more equitable …

Systemic racism is as real as any disease, and our industry is not immune Read More »